CNBC's Joe Kernen reports on the latest news.
Shares in Wegovy maker Novo Nordisk fell around 4% on Friday to their lowest since August 2021, after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the U
Novo Nordisk's weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant. But four years after Wegovy's US launch, the Danish drugmaker's market value has plummeted.
In the closing of the recent trading day, Novo Nordisk (NVO) stood at $47, denoting a -6.06% move from the preceding trading day.
NEW YORK , July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO).  Such investors are advi

Why Novo Nordisk Stock Crumbled Again Today

06:05pm, Thursday, 31'st Jul 2025
The hits just kept coming for beleaguered Ozempic and Wegovy maker Novo Nordisk (NVO -6.05%) on Thursday. The company, which has been slammed with investor sell-offs since cutting its guidance on Tues

Opinion | Novo Nordisk's Weight Loss Lesson

06:00pm, Thursday, 31'st Jul 2025
Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with the older drug Trulicity.

Why Novo Nordisk Stock Plummeted Today

04:58pm, Wednesday, 30'th Jul 2025
Shares of Novo Nordisk (NVO -7.21%) fell on Wednesday, down 7.2% as of market close. The drop comes as the S&P 500 (^GSPC -0.12%) and the Nasdaq Composite (^IXIC 0.15%) fell modestly.

Novo Nordisk: Don't Miss Buying This Dip

02:02pm, Wednesday, 30'th Jul 2025
Novo Nordisk's 20%+ price drop since yesterday following a significant downgrade in sales and profit guidance is a great buying opportunity. The stock's forward P/E is at half the stock's five-year av
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO) on behalf of investors concerning t
In this video, I will talk about Novo Nordisk (NVO -6.21%) and the reasons behind the recent crash. Watch the short video to learn more, consider subscribing, and click the special offer link below.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Novo Nordisk A/S (NYSE: NVO) r
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE